Cogent Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.14
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.51
|
-0.50
|
0.01
|
1.96%
|
|
2022-06-30
|
-0.65
|
-0.71
|
-0.06
|
-9.23%
|
|
2022-03-31
|
-0.52
|
-0.68
|
-0.16
|
-30.77%
|
|
2021-12-31
|
-0.46
|
-0.60
|
-0.14
|
-30.43%
|
|
2021-09-30
|
-0.41
|
-0.48
|
-0.07
|
-17.07%
|
|
2021-06-30
|
-0.36
|
-0.43
|
-0.07
|
-19.44%
|
|
2021-03-31
|
-0.41
|
-0.34
|
0.07
|
17.07%
|
|
2020-12-31
|
-0.51
|
-6.06
|
-5.55
|
-1088.24%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.89
|
|
2021-12-31
|
-1.85
|
|
2020-12-31
|
-12.89
|
|
2019-12-31
|
-4.20
|
|
2018-12-31
|
-3.49
|
|
2017-12-31
|
-1.22
|